Wu Ne N, Bi Yaguang, Ajoolabady Amir, You Fei, Sowers James, Wang Qiurong, Ceylan Asli F, Zhang Yingmei, Ren Jun
Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Department of Cardiology, Xi'an Central Hospital, Xi'an, China.
JACC Basic Transl Sci. 2022 Aug 22;7(8):779-796. doi: 10.1016/j.jacbts.2022.03.007. eCollection 2022 Aug.
Mitochondrial Ca overload contributes to obesity cardiomyopathy, yet mechanisms that directly regulate it remain elusive. The authors investigated the role of Parkin on obesity-induced cardiac remodeling and dysfunction in human hearts and a mouse model of 24-week high-fat diet (HFD) feeding. Parkin knockout aggravated HFD-induced cardiac remodeling and dysfunction, mitochondrial Ca overload, and apoptosis without affecting global metabolism, blood pressure, and aortic stiffness. Parkin deficiency unmasked HFD-induced decline in voltage-dependent anion channel (VDAC) type 1 degradation through the ubiquitin-proteasome system but not other VDAC isoforms or mitochondrial Ca uniporter complex. These data suggest that Parkin-mediated proteolysis of VDAC type 1 is a promising therapeutic target for obesity cardiomyopathy.
线粒体钙超载促成肥胖性心肌病,但其直接调控机制仍不清楚。作者研究了Parkin在人类心脏及24周高脂饮食(HFD)喂养小鼠模型中对肥胖诱导的心脏重塑和功能障碍的作用。Parkin基因敲除加重了HFD诱导的心脏重塑、功能障碍、线粒体钙超载及细胞凋亡,而不影响整体代谢、血压和主动脉僵硬度。Parkin缺乏揭示了HFD诱导的1型电压依赖性阴离子通道(VDAC)通过泛素-蛋白酶体系统降解减少,但不影响其他VDAC亚型或线粒体钙单向转运体复合物。这些数据表明,Parkin介导的1型VDAC蛋白水解是肥胖性心肌病一个有前景的治疗靶点。